NOVEL ICMT INHIBITOR AS POTENTIAL TREATMENT OF RAS-DRIVEN ACUTE MYELOID LEUKEMIA

EHA Library, Miguel Gallardo, 266014

AZACITIDINE (AZA) ENHANCES ANTILEUKEMIC ACTIVITY OF THE MDM2 INHIBITOR MILADEMETAN IN TP53 WILD-TYPE ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Shingo Noguchi, 266015

AUTOMATIC SEPARATION OF ABERRANT CELL CLUSTERS IN STANDARDIZED FLOW CYTOMETRY EXPERIMENTS PROVIDES A HIGHLY REPRODUCIBLE STRATEGY FOR MONITORING MINIMAL RESIDUAL DISEASE IN ACUTE MYELOBLASTIC LEUKEMIA

EHA Library, Vanesa Diaz, 266016

PROGNOSTIC VALUE OF CLONAL HEMATOPOIESIS-MUTATIONS DETECTED AT DIAGNOSIS IN ACUTE MYELOID LEUKEMIA PATIENTS WITH NORMAL KARYOTYPE

EHA Library, Chiara Caprioli, 266017

DIAGNOSTIC VALUE OF PU.1 LOCALIZATION IN ACUTE MYELOID LEUKEMIA WITH MUTATED NPM1

EHA Library, Giulia Pianigiani, 266018

CLUSTER ANALYSIS IDENTIFIES A SPECIFIC IMMUNOPHENOTYPIC PROFILE ASSOCIATED WITH HIGH RISK OF PRIMARY INDUCTION FAILURE AND SHORTER OVERALL AND DISEASE-FREE SURVIVAL IN NPM1-MUTATED AML

EHA Library, Matteo Piccini, 266019

THE RNA HELICASE DDX17 PROTECTS ACUTE MYELOID LEUKEMIA CELLS AGAINST DNA DAMAGE

EHA Library, Prarabdha Jagdhane, 266020

REDIRECTED CYTOTOXICITY AND PROLIFERATION OF T CELLS INDUCED BY BITE® ANTIBODY CONSTRUCTS ARE MODULATED BY THE EXPRESSION PROFILE OF COSTIMULATORY AND COINHIBITORY MOLECULES ON TARGET CELLS IN VITRO

EHA Library, Anetta Marcinek, 266021

PROGNOSTIC IMPACT OF THE 2017 EUROPEAN LEUKEMIANET (ELN) CLASSIFICATION OF YOUNGER ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) TREATED ON CANCER AND LEUKEMIA GROUP B (CALGB)/ALLIANCE PROTOCOLS

EHA Library, Marius Bill, 266022

SIGNIFICANT REDUCTION OF REGULATORY INNATE LYMPHOID CELLS (ILCREGS, CD45+LIN-CD127+IL-10+) AND CD45+LIN-CD127+IL-10- CELLS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA DETECTED BY FLOW CYTOMETRY

EHA Library, Jifeng Yu, 266024

COMPREHENSIVE GENETIC TEST TO DETECT ALL GENE FUSIONS IN HEMATOLOGICAL MALIGNANCIES?

EHA Library, Eva Van Den Berg-De Ruiter, 266025

IDENTIFICATION OF ACUTE MYELOID LEUKAEMIA STEM CELLS AT DIAGNOSIS REVEALS PHENOTYPIC HETEROGENEITY AND IS FEASIBLE IN A CLINICAL LABORATORY

EHA Library, Shir Ying Lee, 266026

THE PROGNOSTIC IMPACT OF LYMPHOCYTE REPERTOIRE RECOVERY AFTER INDUCTION TREATMENT OF CHILDHOOD AML

EHA Library, Michael Svaton, 266027

TUMOR NGS-PANEL UTILITY IN THE IDENTIFICATION OF GERMLINE VARIANTS IN MYELOID MALIGNANCIES

EHA Library, Sara Palomino-Echeverria, 266028

COMBINED TARGETING OF BCL-2 AND SET-PP2A INTERACTION INDUCES POTENT AND SYNERGISTIC ANTI-LEUKEMIC EFFECTS ON ACUTE MYELOID LEUKEMIA

EHA Library, Irene Peris Martínez, 266029

COMBINED INHIBITION OF SHP1 AND SHP2 WITH PHORBOL ESTERS AS A DIFFERENTIATION THERAPY AGAINST ACUTE MYELOID LEUKEMIA

EHA Library, Alejandro Pérez-Fernández, 266030

TARGETING SET-PP2A INTERACTION AS A NOVEL THERAPEUTIC APPROACH FOR MIXED LINEAGE LEUKEMIA (MLL)

EHA Library, ANTONELLA DI MAMBRO, 266031

LONG NON-CODING RNA MANTIS INHIBITS THE PROLIFERATION OF ACUTE MYELOID LEUKEMIA CELL LINE VIA NOTCH SIGNALING PATHWAY

EHA Library, Hongtao Wang, 266033

AN MLL-AF9 ZEBRAFISH LEUKEMIA MODEL

EHA Library, Maryam Saberi, 266035

ANALYSIS OF THE FUNCTION OF HNRNP K IN PATHOGENESIS OF AML WITH DEL(9Q)

EHA Library, Kerstin Rahn, 266037

METFORMIN INHIBITS THE GROWTH OF MYELOID LEUKEMIA CELLS PARTLY DUE TO SUPPRESSION OF TYRO3 EXPRESSION

EHA Library, Tatsuya Saito, 266039

PERSONALIZED FOLLOW-UP OF ACUTE MYELOID LEUKEMIA THROUGH MULTIPARAMETER FLOW CYTOMETRY: A PROOF OF CONCEPT

EHA Library, Hugues Jacqmin, 266041

CONSEQUENCES OF NRAS MUTATIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Anna Durinikova, 266043

THE REGULATORY B CELLS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Hongtao Wang, 266045

NEXT-GENERATION-SEQUENCE-BASED GENE MUTATION DETECTION AND ITS CLINICAL SIGNIFICANCE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA.

EHA Library, Jifeng Yu, 266047

HNRNP K OVEREXPRESSION INDUCE NUCLEOLAR STRESS, A HALLMARK OF ACUTE MYELOID LEUKEMIA

EHA Library, Pedro Aguilar Garrido, 266049

GILTERITINIB PROLONGS SURVIVAL IN PATIENTS WITH FLT3-MUTATED RELAPSED/REFRACTORY AML WHO HAVE COMMON AML CO-MUTATIONS OR A HIGH FLT3-ITD ALLELIC RATIO

EHA Library, Mark Levis, 266051

SAFETY AND RESOURCE UTILIZATION FOLLOWING EARLY HOSPITAL DISCHARGE AFTER INDUCTION CHEMOTHERAPY FOR ACUTE MYELOID LEUKEMIA (AML): A 4-YEAR RETROSPECTIVE ANALYSIS

EHA Library, Nicholas P. Howard, 266053

RESULTS FROM THE FIRST-IN-HUMAN STUDY OF MIVEBRESIB (ABBV-075), A PAN-INHIBITOR OF BROMODOMAIN AND EXTRA TERMINAL PROTEINS, IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Gautam Borthakur, 266054

INCIDENCE AND RISK FACTORS FOR EARLY DEATH AMONG 2421 APL PATIENTS: THE PETHEMA REGISTRY EXPERIENCE

EHA Library, Marta Sobas, 266055

RATIFY: PROGNOSTIC IMPACT OF FLT3 TYROSINE KINASE DOMAIN (TKD) AND NPM1 MUTATION STATUS IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML) TREATED WITH MIDOSTAURIN + STANDARD CHEMOTHERAPY

EHA Library, Maria Teresa Voso, 266056

GEMTUZUMAB OZOGAMICIN COMBINED WITH CYTARABINE FOR ACUTE MYELOID LEUKEMIA PATIENTS IN FIRST RELAPSE

EHA Library, Aude-Marie Fourmont, 266057

REAL-WORLD DATA ON DOSE-RELATED EFFECT OF ARSENIC TRIOXIDE IN THE RELAPSE OF ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Huaiyu Wang, 266058

THE COMBINATION OF BEMCENTINIB, A NOVEL, ORAL, SELECTIVE AXL-INHIBITOR AND LOW-DOSE CYTARABINE YIELDS DURABLE RESPONSES IN AML PATIENTS UNFIT FOR INTENSIVE CHEMOTHERAPY

EHA Library, Sonja Loges, 266059

PROGNOSTIC AND PREDICTIVE IMPACT OF NPM1/FLT3-ITD GENOTYPES AS DEFINED BY 2017 EUROPEAN LEUKEMIANET RISK CATEGORIZATION FROM AML PATIENTS TREATED WITHIN THE INTERNATIONAL RATIFY STUDY

EHA Library, Konstanze DÖHNER, 266060

A RANDOMIZED, OPEN-LABEL, PHASE II STUDY OF SELINEXOR VERSUS PHYSICIAN’S CHOICE (PC) IN OLDER PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Kendra Sweet, 266061

COMPREHENSIVE DIAGNOSTICS OF ACUTE MYELOID LEUKEMIA BY WHOLE TRANSCRIPTOME RNA SEQUENCING

EHA Library, Marieke Griffioen, 266062

DEEP RESPONSE AFTER CPX-351 TREATMENT IN T-AML AND MRC-AML: A REPORT FROM A MULTICENTRIC FRENCH COHORT

EHA Library, Edmond Chiche, 266063

TREATMENT INTENSIFICATION WITH FLAG-IDA MAY IMPROVE DISEASE CONTROL IN YOUNGER PATIENTS WITH SECONDARY AML WHICH MANIFESTS ITSELF WITH LONGER FOLLOW-UP: LONG-TERM ANALYSIS OF THE MRC AML15 TRIAL

EHA Library, Nigel Russell, 266064

GENE MUTATION PROFILE IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA (APL)

EHA Library, Lingyan Zhang, 266065

COMBINING FLOW CYTOMETRY-BASED LEUKEMIC CELL ENRICHMENT AND MUTATIONAL ANALYSIS FOR DETECTION OF RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA: A PILOT STUDY

EHA Library, Albert Wölfler, 266066

RISK ASSESSMENT OF ANTHRACYCLINE CARDIOTOXICITY IN PATIENTS WITH ACUTE LEUKEMIA AND CONCOMITANT ISCHEMIC HEART DISEASE

EHA Library, Tetiana Lymanets, 266067

DECIPHERING THE ABERRANT IMMUNE MICROENVIRONMENT IN ACUTE MYELOID LEUKEMIA DEVELOPMENT AND ITS ROLE IN CHEMOTHERAPY RESPONSE

EHA Library, Heng Mei, 266068

FT-2102, AN IDH1M INHIBITOR, COMBINED WITH AZACITIDINE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) OR MYELODYSPLASTIC SYNDROME (MDS): RESULTS FROM A PHASE 1 STUDY

EHA Library, Jorge E. Cortes, 266069

IS ACUTE MYELOBLASTIC LEUKEMIA IN CHILDREN UNDER TWO YEARS OF AGE A SPECIFIC ENTITY? A REPORT FROM THE FRENCH ELAM02 STUDY GROUP.

EHA Library, Sophie Blais, 266070

USING NEXT-GENERATION SEQUENCING TO PREDICT RESPONSE TO SALVAGE CHEMOTHERAPY WITH HIGH DOSE CYTARABINE AND MITOXANTRONE IN RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Jonathan Canaani, 266071

GLASDEGIB WITH LDAC IN NEWLY DIAGNOSED PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) UNSUITABLE FOR INTENSIVE CHEMOTHERAPY: EFFECTS ON TRANSFUSIONS AND MARROW RECOVERY VS LDAC ALONE

EHA Library, Eunice S Wang, 266072

VENETOCLAX IN COMBINATION WITH LOW DOSE CYTARABINE AND/OR ACTINOMYCIN D IN REAL LIFE RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Andrius Žučenka, 266073

UNMANIPULATED HID COMPARED TO MUD AND ISD HAD SIMILAR GRAFT ANTI-LEUKEMIA EFFECT ON MYELOABLATIVE HSCT FOR AML IN CR

EHA Library, Yue LU, 266074

NAT10 UPREGULATION INDICATES A POOR PROGNOSIS IN ACUTE MYELOID LEUKEMIA

EHA Library, Rong Hu, 266075

QUALITY OF LIFE EVALUATION IN LONG TERM SURVIVORS WITH ACUTE MYELOID LEUKEMIA: A SINGLE CENTER EXPERIENCE

EHA Library, Francesco Tarantini, 266076

ALICE: AN AML STUDY WITH LSD1 INHIBITION IN COMBINATION WITH AZACITIDINE IN THE ELDERLY

EHA Library, Carlos Buesa, 266077

DECITABINE COMBINED WITH HAAG AS INDUCTION CHEMOTHERAPY FOR NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

EHA Library, Xiaowen Tang, 266078

BST-236 - A NOVEL SAFE AND EFFECTIVE FIRST-LINE THERAPY FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA UNFIT FOR STANDARD CHEMOTHERAPY. SUMMARY OF CLINICAL RESULTS TO DATE

EHA Library, Jessica K Altman, 266079

INTENSIVE TREATMENT OF ELDERLY AML PATIENTS IS SAFE AND FEASIBLE, PRINCESS MARGARET CANCER CENTRE EXPERIENCE.

EHA Library, Georgina Stefania Daher Reyes, 266080

CLI24-001: FIRST IN HUMAN STUDY OF SEL24/MEN1703, AN ORAL DUAL PIM/FLT3 KINASE INHIBITOR, IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Simone Baldini, 266081

THE EFFECT OF MODERN THERAPEUTICS IN ADULT ACUTE MYELOID LEUKEMIA (AML): POPULATION-BASED ANALYSIS OF LONG-TERM OUTCOMES FROM THE MANITOBA CANCER REGISTRY

EHA Library, Laura Tapley, 266082

A RETROSPECTIVE STUDY OF MYELOID LEUKAEMIA IN CHILDREN WITH DOWN SYNDROME IN IRELAND

EHA Library, Gavin Dowling, 266083

OCCUPATIONAL PESTICIDES EXPOSURE IS ASSOCIATED WITH AN INCREASED RISK OF ACUTE MYELOID LEUKEMIA: A META-ANALYSIS OF CASE-CONTROL STUDIES INCLUDING 2981 PATIENTS AND 248705 CONTROLS

EHA Library, Amélie FOUCAULT, 266084

ZELLA-101: PHASE 1 STUDY OF ALVOCIDIB FOLLOWED BY 7+3 INDUCTION IN NEWLY DIAGNOSED AML PATIENTS

EHA Library, Stephen ANTHONY, 266085

EARLY ADMISSION IN INTENSIVE CARE UNIT IS ASSOCIATED WITH LOWER MORBIDITY AND MORTALITY IN ACUTE MYELOID LEUKEMIA WITH HYPERLEUKOCYTOSIS: A RETROSPECTIVE ANALYSIS.

EHA Library, Mottaln Mottal, 266086

MIDOSTAURIN IN COMBINATION WITH INTENSIVE CHEMOTHERAPY IS SAFE AND ASSOCIATED WITH IMPROVED REMISSION AND HIGHER TRANSPLANT RATES IN REMISSION - A MULTI-CENTER HISTORICAL CONTROL STUDY

EHA Library, Tamar Berger, 266087

POPULATION PHARMACOKINETIC (POPPK) AND CONCENTRATION-QTC ANALYSIS OF QUIZARTINIB IN PATIENTS (PTS) WITH FLT3-ITD-POSITIVE RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Dongwoo Kang, 266088

SOCIOECONOMIC CONSEQUENCES AND OVERALL COSTS PER PATIENT WITH ACUTE MYELOID LEUKAEMIA (AML) IN SWEDEN - A POPULATION-BASED STUDY USING MULTIPLE NATIONAL REGISTRIES

EHA Library, Simona Vertuani, 266089

INCIDENCE AND PROGNOSTIC IMPACT OF A BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM-LIKE PHENOTYPE IN AML PATIENTS.

EHA Library, Fabio Guolo, 266090

A PHASE 1B/2 CLINICAL STUDY OF TARGETED IDH1 INHIBITION WITH IVOSIDENIB, IN COMBINATION WITH THE BCL-2 INHIBITOR VENETOCLAX, FOR PATIENTS WITH IDH1-MUTATED (MIDH1) MYELOID MALIGNANCIES.

EHA Library, Courtney DiNardo, 266091

LOW-DOSE CYTARABINE WITH OR WITHOUT GLASDEGIB IN NEWLY DIAGNOSED PATIENTS WITH ACUTE MYELOID LEUKEMIA: LONG-TERM ANALYSIS OF A PHASE 2 RANDOMIZED TRIAL

EHA Library, Cristina papayannidis, 266092

PHASE 3 EXPLORATORY ANALYSIS OF OUTCOMES IN OLDER ADULTS WITH NEWLY DIAGNOSED, HIGH-RISK/SECONDARY AML WHO ACHIEVED REMISSION WITH CPX-351 VERSUS 7+3 INDUCTION

EHA Library, Stefan Faderl, 266093

IMPROVED OUTCOMES IN PATIENTS (PTS) WITH BCL2-POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH VENETOCLAX (VEN) PLUS R-CHOP: RESULTS FROM THE PHASE 2 CAVALLI STUDY

EHA Library, Franck Morschhauser, 266094

POPULATION-BASED STUDY ON DIFFERENT REGIMENS OF R-CHOP IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA IN THE NETHERLANDS SUPPORTS THE USE OF 6 CYCLES OF R-CHOP21

EHA Library, Djamila Issa, 266095

UPDATE OF THE SINGLE-ARM PHASE II L-MIND STUDY OF MOR208 PLUS LENALIDOMIDE IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: HIGH OVERALL RESPONSE RATES IN PATIENT SUBGROUPS WITH POOR PROGNOSIS

EHA Library, Johannes Düll, 266096

COMPARISON OF RITUXIMAB DOSE-ADJUSTED EPOCH (R-DA-EPOCH) WITH RITUXIMAB-CHOP (R-CHOP) CHEMOTHERAPY IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL)

EHA Library, Theodoros Vassilakopoulos, 266097

LISOCABTAGENE MARALEUCEL TREATMENT OF PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN LYMPHOMA AND SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA: INITIAL RESULTS FROM TRANSCEND NHL 001

EHA Library, Jeremy Abramson, 266098

EARLY RESPONSE OBSERVATION OF PEDIATRIC PATIENTS WITH BURKITT'S LYMPHOMA TREATED WITH CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS

EHA Library, Wenqun zhang, 266099

DOSE ESCALATION OF TINOSTAMUSTINE IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) LYMPHOID MALIGNANCIES

EHA Library, Delphine Remmy, 266100

REDUCED-INTENSITY IMMUNOCHEMOTHERAPY WITHOUT VINCRISTINE IN ELDERLY PATIENTS OLDER THAN 80 YEARS OLD WITH DIFFUSE LARGE B-CELL LYMPHOMA: A MULTICENTRE, OPEN-LABEL, SINGLE-ARM, PHASE II TRIAL

EHA Library, Isao Yoshida, 266101

CENTRAL NERVOUS SYSTEM RELAPSE IN DIFFUSE LARGE B CELL LYMPHOMA: RISK FACTORS AND ROLE OF INTRATHECAL PROPHYLAXIS.

EHA Library, Eleonora ALMA, 266102

THE IMPACT OF EZH2 MUTATIONS (Y641N/Y641F/Y641H/Y641S) ON DISEASE-FREE SURVIVAL OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: A STROBE-COMPLIANT COHORT STUDY

EHA Library, Myrna Candelaria, 266103

OSTEOPOROSIS AND LOW-ENERGY FRACTURES AFTER TREATMENT FOR LYMPHOMA WITH CORTICOSTEROID-CONTAINING IMMUNOCHEMOTHERAPY: A DANISH NATIONWIDE COHORT STUDY

EHA Library, Joachim Baech, 266104

ANALYSES OF CYTOKINE RELEASE SYNDROME AND NEUROTOXICITY BY AGE AND LYMPHODEPLETING CHEMOTHERAPY USE IN ADULTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH TISAGENLECLEUCEL

EHA Library, Richard Maziarz, 266105

A PHASE 2 STUDY OF OFATUMUMAB IN COMBINATION WITH HYPER-CVAD/MA IN PATIENTS WITH NEWLY DIAGNOSED MANTLE CELL LYMPHOMA

EHA Library, Pallawi Torka, 266106

POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN LIVER AND KIDNEY TRANSPLANT RECIPIENTS OVER 33 YEARS: A SINGLE-CENTRE EXPERIENCE

EHA Library, MARTA LOPES, 266107

PROGNOSTIC FACTORS AND IMMUNOHISTOCHEMICAL PROFILE IN PRIMARY REFRACTORY AND RECURRENT DIFFUSE LARGE B-CELL LYMPHOMAS

EHA Library, Henrik Lampikoski, 266108

IMPACT OF LATE RELAPSES ON OUTCOMES IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

EHA Library, Priyanka Raheja Makhija, 266109

A SYSTEMATIC REVIEW OF THE CLINICAL EFFICACY OF TREATMENTS IN RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (R/R DLBCL)

EHA Library, Per-Olof Thuresson, 266110

ISOLATED PRIMARY ADRENAL LYMPHOMA (IPAL) - AN EMERGING LYMPHOMA ENTITY? RESULTS OF A RETROSPECTIVE MULTICENTER STUDY

EHA Library, Majidi Majidi, 266111

RESPONSES TO R-CHOP CHEMOTHERAPY INCORPORATING BIOSIMILAR RITUXIMAB (TRUXIMA®) FOR THE FIRST LINE TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA - INITIAL EXPERIENCE AT UNIVERSITY COLLEGE LONDON HOSPITAL

EHA Library, Simon Cheesman, 266112

NEW TREATMENT FOR DOUBLE/TRIPLE HIT LYMPHOMA WITH DOSE INTENSE PROTOCOL: RITUXIMAB,DOXORUBICIN,ETOPOSIDE,PREDNISOLONE/GEMCITABINE+OXALIPLATIN SHAWING BETTER SURVIVAL RATE

EHA Library, Maher Salamoon, 266113

REAL WORLD CLINICAL EFFECTIVENESS AND SAFETY OF CT-P10 IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: INTERIM RESULTS FROM A EUROPEAN NON-INTERVENTIONAL POST-AUTHORISATION SAFETY STUDY

EHA Library, Pier Luigi Zinzani, 266114

CLINICAL VALUE OF DIFFUSION-WEIGHTED WHOLE-BODY IMAGING WITH BACKGROUND BODY SIGNAL SUPPRESSION IN NEWLY DIAGNOSED LYMPHOMA PATIENTS

EHA Library, Haiwen Huang, 266115

THE CLINICAL CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH AGGRESSIVE LARGE CELL LYMPHOMA AND DIABETES MELLITUS

EHA Library, Oren Pasvolsky, 266116

ELEVATION OF SERUM IL-10 IS ASSOCIATED WITH ADVERSE CLINICAL OUTCOMES IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA WHO WERE TREATED WITH R-CHOP

EHA Library, Jun Ho Yi, 266117

IMPORTANCE OF DIAGNOSIS-TO-TREATMENT INTERVAL IN NEWLY DIAGNOSED PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Masahiro Yoshida, 266118

A DUAL CENTRE EXPERIENCE OF HAEMOPHAGOCYTOSIS REVEALS ULTRA-HIGH FERRITIN (>50,000 NG/ML) AND NEUTROPENIA AS PREDICTORS OF MORTALITY.

EHA Library, Catherine hockings, 266119

VENOUS THROMBOSIS AND BASELINE C-REACTIVE PROTEIN ARE INDEPENDENT PROGNOSTIC MARKERS IN DIFFUSE LARGE B-CELL LYMPHOMA AND IDENTIFY A GROUP OF PATIENTS WITH SIGNIFICANTLY INFERIOR OUTCOMES

EHA Library, Mark Grech, 266120

REAL-WORLD TREATMENT PATTERNS OF PATIENTS DIAGNOSED WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) IN THE UNITED STATES (US)

EHA Library, Xiaoqin Yang, 266121

APPROACH TO DOUBLE HIT LYMPHOMA (DHL) DIAGNOSIS AND TREATMENT IN EUROPE - A CROSS-SECTION STUDY OF EHA LYMPHOMA WORKING PARTY (EHA LYG)

EHA Library, Igor Aurer, 266122

DOUBLE-HIT DIFFUSE LARGE B-CELL LYMPHOMA IN TAIWAN IS PREDOMINANTLY BCL6-REARRANGED AND OVEREXPRESSION OF MYC AND BCL6 IS NOT A GOOD SURROGATE FOR SCREENING

EHA Library, T-Y Chao, 266123

RITUXIMAB DOSE ASSOCIATED WITH OVERALL SURVIVAL IN DIFFUSE LARGE B CELL LYMPHOMA

EHA Library, Jee Hyun Kong, 266124

REAL - LIFE DATA ON ROMIDEPSIN TREATMENT ‎FOR RELAPSED AND REFRACTORY PERIPHERAL AND ‎CUTANEOUS T-CELL LYMPHOMA - A ‎MULTICENTER NATIONAL OBSERVATIONAL STUDY

EHA Library, Shai Shimony, 266125